Document:

Exhibit 10.4

 

SHAREHOLDERS AGREEMENT

 

dated as of

 

November  , 2021

 

among

 

CI&T INC

 

and

 

CERTAIN SHAREHOLDERS OF CI&T INC

 

    

     

    

 

TABLE OF CONTENTS

 

	 	 	 	 
	 	 	PAGE
	
    ARTICLE 1

    DEFINITIONS
	 	 	 
	 	 
	Section 1.01. Definitions	 	 	1
	Section 1.02. Other Definitional and Interpretative Provisions	 	 	3
	 	 	 	 
	
    ARTICLE 2

    CORPORATE
    GOVERNANCE
	 	 	 
	 	 
	Section 2.01. Composition of the Board	 	 	3
	Section 2.02. Removal	 	 	3
	Section 2.03. Vacancies	 	 	3
	 	 	 	 
	
    ARTICLE 3

    MISCELLANEOUS
	 	 	 
	 	 
	Section 3.01. Binding Effect; Assignability; Benefit	 	 	4
	Section 3.02. Notices	 	 	4
	Section 3.03. Term; Waiver; Amendment	 	 	5
	Section 3.04. Fees and Expenses	 	 	5
	Section 3.05. Governing Law; No Jury Trial	 	 	6
	Section 3.06. Specific Enforcement	 	 	6
	Section 3.07. Counterparts; Effectiveness	 	 	6
	Section 3.08. Entire Agreement	 	 	6
	Section 3.09. Severability	 	 	6

 

    

     

    

 

SHAREHOLDERS AGREEMENT

 

This SHAREHOLDERS AGREEMENT (as the same may be amended from time to
time in accordance with its terms, the “Agreement”) is entered into as of November  , 2021, by and among CI&T
Inc, an exempted company incorporated under the laws of the Cayman Islands (the “Company”), and each Shareholder whose
name appears on the signature pages hereto.

 

W I T N E S S E T H:

 

WHEREAS, the Company is currently contemplating an underwritten initial
public offering (the “IPO”) of its Class A Common Shares;

 

WHEREAS, in connection with, and effective upon, the completion of
the IPO (such date of completion, the “IPO Date”), the Company and the Shareholders (as defined in Section 1.01
hereof) wish to set forth certain understandings between such parties, including with respect to certain governance matters; and

 

NOW, THEREFORE, in consideration of the covenants and agreements contained
herein, the parties hereto agree as follows:

 

ARTICLE 1 

DEFINITIONS

 

Section 1.01. Definitions. (a) As used in this Agreement,
the following terms have the following meanings:

 

“Advent Shareholders” means, at any time, shareholders
affiliated with Advent International Corporation, including AI Calypso Brown LLC, AI Iapetus Grey LLC and AI Titan Black LLC.

 

“Affiliate” means, in respect of a Person, any other
Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with,
such Person, and (i) in the case of a natural person, shall include, without limitation, such person’s spouse, parents, children,
siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or any relative up to
the second degree, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly
owned by any of the foregoing, and (ii) in the case of an entity, shall include a partnership, a corporation or any natural person
or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with,
such entity. For the purpose of this definition, the term “control” (including, with correlative meanings, the terms
 “controlling”, “controlled by” and “under common control with”), as used with
respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of such Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Aggregate Voting Power” means, with respect to
any Shareholder or group of Shareholders, the total voting power of the total number of Shares (as determined on a Common Equivalents
basis) entitled to vote generally in the election of the Company’s Directors that are “beneficially owned” (as such
term is defined in Rule 13d-3 of the Exchange Act) (without duplication) by such Shareholder or group of Shareholders as of the date
of such calculation.

 

“Articles of Association” means the Amended and
Restated Memorandum and Articles of Association of the Company, as the same may be amended from time to time.

 

“Board” means the board of directors of the Company.

 

“Business Day” means any day except a Saturday,
Sunday or other day on which commercial banks in the Cayman Islands, New York City or Campinas City, São Paulo State, Brazil are
authorized by law to close.

 

     1 

     

    

 

“Common Equivalents” means (i) with respect
to Common Shares, the number of Shares, (ii) with respect to any Company Securities that are convertible into or exchangeable for
Common Shares, the number of Shares issuable in respect of the conversion or exchange of such securities into Common Shares.

 

“Class A Common Shares” means the Class A
common shares, par value $0.00005 per share, of the Company and any other security into which such Class A Common Shares may hereafter
be converted or changed.

 

“Class B Common Shares” means the Class B
common shares, par value $0.00005 per share, of the Company and any other security into which such Class B Common Shares may hereafter
be converted or changed.

 

“Common Shares” means collectively, the Class A
Common Shares and the Class B Common Shares (provided that in no circumstance shall such shares be counted twice).

 

“Company Securities” means (i) the Common Shares
and (ii) securities that entitle the holder to vote in the election of directors to the Board that are convertible into or exchangeable
for Common Shares.

 

“Directors” has the meaning given to that term in
the Articles of Association.

 

“Exchange Act” means the Securities Exchange Act
of 1934, as amended.

 

“Founder Shareholders” means, at any time (i) Cesar
Nivaldo Gon, and any Person (other than the Company) affiliated with and vehicles controlled by Cesar Nivaldo Gon, including ENIAC Capital
Group Ltd., (ii) Fernando Matt Borges Martins, and any Person (other than the Company) affiliated with and vehicles controlled by
Fernando Matt Borges Martins, including Guaraci Investments Ltd. (iii) Bruno Guiçardi, and any Person (other than the Company)
affiliated with and vehicles controlled by Bruno Guiçardi, including the Ferreira Guiçardi Family Trust.

 

“Necessary Action” means, with respect to a specified
result, all actions (to the extent such actions are permitted by law and by the Articles of Association) necessary to cause such result,
including (i) requisitioning a meeting of shareholders, voting or providing a written consent or proxy with respect to the Company
Securities, (ii) causing the adoption of shareholders’ resolutions and amendments to the Articles of Association, (iii) executing
agreements and instruments, and (iv) making, or causing to be made, with governmental, administrative or regulatory authorities,
all filings, registrations or similar actions that are required to achieve such result.

 

“Person” means an individual, company, corporation,
limited liability company, partnership, association, trust or other entity or organization, including a government or political subdivision
or an agency or instrumentality thereof.

 

“Permitted Assigns” means with respect to any of
the Shareholders, any of their respective Affiliates who is a transferee of Shares (which are transferred other than pursuant to a widely
distributed public sale) that agrees in writing to become party to, and be bound to the same extent as its transferor by the terms of,
this Agreement, in the form of Exhibit A hereto; provided, that upon such Transfer, such Permitted Assign shall be deemed to be a
 “Shareholder” hereto for all purposes herein.

 

“Shareholders” means at any time, the Founder Shareholders
and Advent Shareholders and any Person (other than the Company) affiliated with the Founder Shareholders and Advent Shareholders and any
of their Permitted Assigns who in each case shall then be a party to or bound by this Agreement, so long as such Person shall “beneficially
own” (as such term is defined in Rule 13d-3 of the Exchange Act) any Company Securities.

 

“Shares” means the outstanding Common Shares.

 

“Subsidiary” means, with respect to any Person,
any entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors
or other persons performing similar functions are at the time directly or indirectly owned by such Person.

 

     2 

     

    

 

Section 1.02. Other Definitional and Interpretative Provisions.
The words “hereof”, “herein” and “hereunder” and words of like import used in this Agreement shall
refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein are included for convenience
of reference only and shall be ignored in the construction or interpretation hereof. References to Articles, Sections, Exhibits and Schedules
are to Articles, Sections, Exhibits and Schedules of this Agreement unless otherwise specified. All Exhibits and Schedules annexed hereto
or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms
used in any Exhibit or Schedule, but not otherwise defined therein, shall have the meaning as defined in this Agreement. Any singular
term in this Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words “include”,
 “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without
limitation”, whether or not they are in fact followed by those words or words of like import. “Writing”, “written”
and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References
to any agreement or contract are to that agreement or contract as amended, modified or supplemented from time to time in accordance with
the terms hereof and thereof; provided that with respect to any agreement or contract listed on any schedules hereto, all such
amendments, modifications or supplements must also be listed in the appropriate schedule. References to any law include all rules and
regulations promulgated thereunder. References to any Person include the successors and permitted assigns of that Person. References from
or through any date mean, unless otherwise specified, from and including or through and including, respectively.

 

ARTICLE 2 

CORPORATE
GOVERNANCE

 

Section 2.01. Composition of the Board. (a) The members
of the Board shall be nominated and elected in accordance with the Articles of Association and the provisions of this Agreement. Effective
as of the IPO Date, the Board shall be comprised of seven Directors, which directors shall initially be Fernando Matt Borges Martins,
Brenno Raiko de Souza, Cesar Nivaldo Gon, Patrice Philippe Nogueira Baptista Etlin, Silvio Romero de Lemos Meira, Maria Helena dos Santos
Fernandes de Santana and Eduardo Campozana Gouveia.

 

(b) From and after the IPO Date, pursuant to Article 21.4
of the Articles of Association, the Company grants to the Founder Shareholders, and the Founder Shareholders shall have, the right, but
not the obligation, to nominate and appoint as Directors to the Board, a number of designees, equal to up to four designees (or if the
size of the Board is increased, a majority (i.e. more than 50%) of the total number of Directors appointed to the Board, rounded upward
to the nearest whole number), so long as this Agreement remains in full force and effect.

 

(c) From and after the IPO Date, pursuant to Article 21.4
of the Articles of Association, the Company grants to the Advent Shareholders, and the Advent Shareholders shall have, the right, but
not the obligation, to nominate and appoint as Directors to the Board, a number of designees, equal to: (i) up to two designees,
so long as the Advent Shareholders’ Aggregate Voting Power of Shares (as determined on a Common Equivalents basis) continues to
be at least 20% of the total voting power of all Shares (as determined on a Common Equivalents basis), and (ii) up to one designee,
so long as the Advent Shareholders’ Aggregate Voting Power of Shares (as determined on a Common Equivalents basis) is (x) less
than 20% of the total voting power of all Shares and (y) at least 10% of the total voting power of all Shares, each as determined
on a Common Equivalents basis.

 

(d) Each party agrees, to the fullest extent permitted by applicable
law (including with respect to any applicable fiduciary duties under Cayman Islands law), to take all Necessary Action to effectuate the
nomination and appointment of Directors by the Shareholders in accordance with this Section 2.01.

 

(e) For the avoidance of doubt, the rights granted to the Shareholders
to appoint Directors to the Board pursuant to this Agreement are granted pursuant to Article 21.4 of the Articles of Association
and are in addition to, and not intended to limit in any way, the other rights that the Shareholders or any of their respective Affiliates
may have to nominate, elect or remove directors under the Articles of Association or Cayman Islands law.

 

Section 2.02. Appointment, Removal and Replacement. The
Shareholders may only appoint, remove or replace a Director by giving the Company written notice of the appointment, removal or replacement
of such Director and the date the appointment, removal or replacement is to take effect, provided that where a Director is removed or
resigns or otherwise vacates its office as Director, that Director may only be replaced by a person nominated and appointed by that same
shareholder.

 

Section 2.03. Vacancies. Subject to the provisions of this
Agreement, the Board may nominate additional Directors to the Board, or fill any vacancy on the Board, pursuant to Article 21.3 of
the Articles of Association.

 

     3 

     

    

 

ARTICLE 3 

MISCELLANEOUS

 

Section 3.01. Binding Effect; Assignability; Benefit. (a) Except
as otherwise provided herein, this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
heirs, successors, legal representatives and permitted assigns. Any Shareholder that ceases to beneficially own any Company Securities
shall cease to be bound by the terms hereof (other than Sections 3.02, 3.05, 3.06, 3.08 and 3.09).

 

(b) Neither the Company nor any of the Shareholders shall assign
or transfer all or any part of this Agreement without the prior written consent of the other parties hereto; provided, however, that the
Shareholders shall be entitled to assign, in whole or in part, to any of their Permitted Assigns without such prior written consent. Any
such Permitted Assignee that shall become a party to this Agreement shall (unless already bound hereby) execute and deliver to the Company
an agreement to be bound by this Agreement in the form of Exhibit A hereto and shall thenceforth be a “Shareholder.”

 

(c) Nothing in this Agreement, expressed or implied, is intended
to confer on any Person other than the parties hereto, and their respective heirs, successors, legal representatives and permitted assigns,
any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

Section 3.02. Notices. All notices, requests and other
communications to any party shall be in writing and shall be delivered in person, mailed by certified or registered mail, return receipt
requested, or sent by facsimile transmission or email transmission so long as receipt of such email is requested and received:

 

if to the Company to:

 

CI&T Inc

Rua Doutor Ricardo Benetton Martins, n. 1000, Prédio 23B

Loteamento II do Polo de Tecnologia - Campinas/SP

13086-902- Brazil

Attention: Stanley Rodrigues and Marcela Masiero Lindner

E-mail: stanley@ciandt.com; mmasiero@ciandt.com

 

if to the Founder Shareholders, to:

 

Guaraci Investments Ltd. 

Craigmuir Chambers, Road Town, Tortola 

VG 1110, British Virgin Islands 

Attention: Fernando Matt 

E-mail: fernando@ciandt.com

 

Bruno Guiçardi 

1 Surrey Rd, Summit, NJ 

07901-3218, United States of America 

Attention: Bruno Guiçardi 

E-mail: bruno@ciandt.com

 

Ferreira Guiçardi Family Trust 

The Goldman Sachs Trust Company 

200 Bellevue Parkway, Suite 250 | Wilmington, DE 19809E-mail:
bruno@ciandt.com

 

ENIAC Capital Group Ltd. 

Craigmuir Chambers, Road Town, Tortola 

VG 1110, British Virgin Islands 

Attention: Cesar Gon 

E-mail: gon@ciandt.com

 

     4 

     

    

 

if to the Advent Shareholders, to:

 

AI Calypso Brown LLC 

AI Iapetus Grey LLC 

AI Titan Black LLC 

Av. Brig. Faria Lima 3311, 9o andar, 04538-133 

São Paulo, SP, Brasil 

Attention: Brenno Raiko, Marcelo Penna and Priscila Antunes 

E-mail: mpenna@adventinternational.com.br; pantunes@adventinternational.com.br

 

All notices, requests and other communications shall be deemed received
on the date of receipt by the recipient thereof if received prior to 5:00 p.m. in the place of receipt and such day is a Business
Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the
next succeeding Business Day in the place of receipt. Any notice, request or other written communication sent by facsimile transmission
shall be confirmed by certified or registered mail, return receipt requested, posted within one Business Day, or by personal delivery,
whether courier or otherwise, made within two Business Days after the date of such facsimile transmissions.

 

Any Permitted Assignee that becomes a Shareholder shall provide its
address, fax number and email address to the Company.

 

Section 3.03. Term; Waiver; Amendment. This Agreement shall
terminate (a) at such time as the Founder Shareholders’ Aggregate Voting Power of Shares (as determined on a Common Equivalents
basis) ceases to be at least 30% of the total voting power of all Shares (as determined on a Common Equivalents basis), (b) at such
time as the Advent Shareholders’ Aggregate Voting Power of Shares (as determined on a Common Equivalents basis) ceases to be at
least 10% of the total voting power of all Shares (as determined on a Common Equivalents basis) or (c) as it relates to each Shareholder
on the earlier to occur of: (i) any Shareholder ceases to beneficially own any Company Securities, and (ii) upon the delivery
of a written notice by such Shareholder to the Company requesting that this Agreement terminate as it relates to such Shareholder (in
each case, other than 3.02, 3.05, 3.06, 3.08 and 3.09).

 

(b) This Agreement may be amended, waived or otherwise modified
only by a written instrument executed by the parties hereto. In addition, any party may waive any provision of this Agreement with respect
to itself by an instrument in writing executed by the party against whom the waiver is to be effective. Except as provided in the preceding
sentences, no action taken pursuant to this Agreement, including any investigation by or on behalf of any party, will be deemed to constitute
a waiver by the party taking such action of compliance with any covenants or agreements contained herein. The waiver by any party hereto
of a breach of any provision of this Agreement will not operate or be construed as a waiver of any subsequent breach.

 

Section 3.04. Fees and Expenses. All costs and expenses
incurred in connection with the preparation of this Agreement, or any amendment or waiver hereof, and the transactions contemplated hereby
shall be paid by the party incurring such costs or expenses.

 

     5 

     

    

 

Section 3.05. Governing Law; No Jury Trial. (a) This
Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of New York, without regard to the
conflict of laws principles thereof that would result in the application of any law other than the laws of the State of New York. EACH
OF THE PARTIES HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT
TO ANY COURT PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF AND PERMITTED UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED BY THIS AGREEMENT. EACH OF THE PARTIES HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT,
AS APPLICABLE.

 

(b)With respect to any Action relating to or arising out of this Agreement,
each party to this Agreement irrevocably (i) consents and submits to the exclusive jurisdiction of the courts of the State of New
York and any court of the United States located in the Borough of Manhattan in New York City; (ii) waives any objection which such
party may have at any time to the laying of venue of any Action brought in any such court, waives any claim that such Action has been
brought in an inconvenient forum and further waives the right to object, with respect to such Action, that such court does not have jurisdiction
over such party; and (iii) consents to the service of process at the address set forth for notices in Section 3.02 herein; provided,
however, that such manner of service of process shall not preclude the service of process in any other manner permitted under applicable
law.

 

Section 3.06. Specific Enforcement. Each party hereto acknowledges
that the remedies at law of the other parties for a breach or threatened breach of this Agreement would be inadequate and, in recognition
of this fact, any party to this Agreement, without posting any bond, and in addition to all other remedies that may be available, shall
be entitled to obtain equitable relief in the form of specific performance, a temporary restraining order, a temporary or permanent injunction
or any other equitable remedy that may then be available.

 

Section 3.07. Counterparts; Effectiveness. This Agreement
may be executed in any number of counterparts, each of which shall be deemed to be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. This Agreement shall become effective upon completion of the IPO on the IPO Date; provided,
that this Agreement shall be of no force and effect (i) prior to the completion of the IPO and (ii) if the IPO has not been
consummated within thirty (30) Business Days from the date of this Agreement. Until and unless each party has received a counterpart hereof
signed by the other party hereto, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether
by virtue of any other oral or written agreement or other communication).

 

Section 3.08. Entire Agreement. This Agreement sets forth
the entire understanding of the parties hereto with respect to the subject matter hereof. There are no agreements, representations, warranties,
covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein. This Agreement supersedes
all other prior agreements and understandings between the parties with respect to such subject matter.

 

Section 3.09. Severability. If any term, provision, covenant
or restriction of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in
no way be affected, impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not
affected in any manner materially adverse to any party. Upon such a determination, the parties shall negotiate in good faith to modify
this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner so that the transactions
contemplated hereby be consummated as originally contemplated to the fullest extent possible.

 

     6 

     

    

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed by their respective authorized officers as of the day and year first above written.

 

	 	THE COMPANY:
	 	 
	 	CI&T
INC
	 	 
	 	By: 
	 	Name:
	 	Title:
	 	 
	 	THE SHAREHOLDERS:
	 	 
	 	ENIAC
CAPITAL GROUP LTD.
	 	 
	 	By: 
	 	Name:
	 	Title:
	 	 
	 	GUARACI
INVESTMENTS LTD.
	 	 
	 	By: 
	 	Name:
	 	Title:
	 	 
	 	BRUNO
GUIÇARDI
	 	 
	 	By: 
	 	Name:
	 	Title:
	 	 
	 	FERREIRA
GUIÇARDI FAMILY TRUST
	 	 
	 	By:
	 	Name:
	 	Title:
	 	 
	 	AI
CALYPSO BROWN LLC
	 	 
	 	By: 
	 	Name:
	 	Title:
	 	 
	 	AI
IAPETUS GREY LLC
	 	 
	 	By: 
	 	Name:
	 	Title:
	 	 
	 	AI
TITAN BLACK LLC
	 	 
	 	By: 
	 	Name:
	 	Title:

 

    

     

    

  

EXHIBIT A

 

JOINDER TO SHAREHOLDERS AGREEMENT

 

This Joinder Agreement (this “Joinder Agreement”)
is made as of the date written below by the undersigned (the “Joining Party”) in accordance with the Shareholders Agreement
dated as of November  , 2021 (as amended, amended and restated or otherwise modified from time to time, the “Shareholders
Agreement”), as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning
ascribed to such terms in the Shareholders Agreement.

 

The Joining Party hereby acknowledges, agrees and confirms that, by
its execution of this Joinder Agreement, the Joining Party shall be deemed to be a party to the Shareholders Agreement as of the date
hereof and shall have all of the rights and obligations of a “Shareholder” thereunder as if it had executed the Shareholders
Agreement. The Joining Party hereby ratifies, as of the date hereof, and agrees to be bound by, all of the terms, provisions and conditions
contained in the Shareholders Agreement.

 

IN WITNESS WHEREOF, the undersigned has executed this Joinder Agreement
as of the date written below.

 

Date: ,

 

	 	[NAME OF JOINING PARTY]
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 
	 	Address for Notices:

 

	Acknowledged by:	 
	 	 
	CI&T INC	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:Exhibit 10.1

 

EXECUTIVE EMPLOYMENT AGREEMENT

 

This Executive Employment
Agreement (the “Agreement”), is made and entered into as of October 29, 2021 (the “Effective Date”), by and
between Evolv Technologies Holdings, Inc. (“Company”), and Mario Ramos (“Executive”) (each a “Party,”
and collectively the “Parties”).

 

WHEREAS,
Company wishes to employ Executive as an employee of Company and the Executive wishes to be employed as an employee of Company on the
terms set forth below;

 

WHEREAS,
Executive represents that he possesses the necessary skills to perform the duties of this position and that he has no obligation to any
other person or entity which would prevent, limit or interfere with his ability to do so;

 

WHEREAS,
with the approval of the Company’s Compensation Committee of the Board of Directors (the “Board”), Executive and Company
desire to enter into this Agreement to assure the harmonious performance of the affairs of Company.

 

NOW,
THEREFORE, in consideration of the mutual promises, terms, provisions, and conditions contained herein, the Parties agree as
follows:

 

1.           Duties.
Subject to the terms and conditions of this Agreement, Company shall employ Executive as its
Chief Financial Officer and Chief Risk Officer (“CFO/CRO”), reporting directly to Company’s Chief Executive Officer.
In this role, you will be most senior person in both the Finance and Risk functions. Executive accepts such employment upon the terms
and conditions set forth herein, and agrees to perform to the best of his ability the duties normally associated with such position and
as determined by Company in its sole discretion. During Executive’s employment, Executive shall devote substantially all of his
business time and energies to the business and affairs of Company, provided that nothing in this Agreement shall prohibit Executive
from engaging in activities that are not competitive with the business of Company and shall not interfere with the performance of Executive’s
duties for Company; in addition, nothing contained in this Section 1 shall prevent or limit Executive’s right to manage his
personal investments on his own personal time including, without limitation the right to make passive investments in the securities of
any publicly held entity so long as Executive’s aggregate direct and indirect interest does not exceed two percent (2%) of the issued
and outstanding securities of any class of securities of such publicly held entity.

 

2.            Term
of Employment.

 

(a)          Term.
Subject to the terms hereof, Executive’s employment hereunder shall commence on November 1, 2021 (the “Commencement Date”)
and shall continue until terminated hereunder by either Party in accordance with this Agreement (such term of employment referred to herein
as the “Term”).

 

(b)         Termination.
Notwithstanding anything else contained in this Agreement, Executive’s employment hereunder shall terminate upon the earliest to
occur of the following:

 

(i)            Death.
Immediately upon Executive’s death.

 

(ii)           Termination
by Company.

 

     

     

    

 

(A)          If
for Cause (as defined below), written notice by Company to Executive under Section 2(c) that Executive’s employment is
being terminated for Cause, which termination shall be effective on the date of such notice or such later date as specified in writing
by Company; or

 

(B)           If
by Company without Cause, written notice by Company to Executive that Executive’s employment is being terminated, which termination
shall be effective immediately after the date of such notice or such later date as specified in writing by Company.

 

(iii)          Termination
by Executive.

 

(A)         If
for Good Reason (as defined below), written notice by Executive to Company under Section 2(d) that Executive is terminating
Executive’s employment for Good Reason and that sets forth the factual basis supporting the alleged Good Reason, which termination
shall be effective thirty (30) days after the date of such notice; provided that if Company has cured the circumstances giving
rise to the Good Reason as described in Section 2(d), then such termination shall not be effective; or

 

(B)          If
without Good Reason, written notice by Executive to Company that Executive is terminating Executive’s employment, which termination
shall be effective ninety (90) days after the date of such notice or such earlier date as determined in the sole discretion of Company.

 

Notwithstanding anything in
this Section 2(b), Company may at any point terminate Executive’s employment for Cause prior to the effective date of any other
termination contemplated hereunder.

 

(c)         Definition
of “Cause”. For the purposes of this Agreement, “Cause” shall mean: (i) conduct constituting fraud, embezzlement,
or illegal misconduct in connection with the performance of Executive’s duties under this Agreement; (ii) Executive’s
commission of, or voluntary and freely given confession to, or plea of guilty or nolo contendere to, a crime which constitutes
a felony (other than a traffic violation), an indictment that results in material injury to Company’s property, operation, or reputation,
or a misdemeanor involving moral turpitude; (iii) Executive’s willful failure to perform his employment duties or obligations
(except resulting from incapacity or illness) as reasonably and lawfully directed by Company that continues after (A) Company or
its duly authorized designee delivers a written notice to Executive describing such willful failure, and (B) Executive has failed
to cure or take substantial steps to cure such willful failure after a reasonable time period as determined by Company or its duly authorized
designee in its, his or her, as the case may be, reasonable discretion (not to be less than 30 days); (iv) willful misconduct or
gross negligence that is materially injurious to the business, reputation or property of Company; (v) alcohol or substance abuse
that materially interferes with the performance by Executive of his duties or obligations; (vi) repeated absence from work (either
in-person or remote) during normal business hours for reasons other than permitted absence; (vii) violation of Executive’s
Non-Competition, Non-Solicitation, Non-Disclosure, and Intellectual Property Agreement (as described in Section 5); and (viii) repeated
violation of any of the material policies or practices of Company (including, but not limited to, discrimination or harassment), or a
single serious violation of such policies or practices which Company, in its reasonable discretion, determines is materially injurious
to the business or reputation of Company.

 

     

     

    

 

(d)         Definition
of “Good Reason”. For the purposes of this Agreement, “Good Reason” shall mean: (i) a material diminution
in Executive’s authority or responsibilities that causes Executive’s position with Company to become of less authority or
responsibility than his position immediately prior to such change or a change to Executive’s reporting line, (ii) a material
reduction in Executive’s then current Base Salary or Target Amount of the Annual Bonus by Ten Percent (10%) or more, or (iii) a
change in the principal location, at Company’s request and direction, at which Executive performs his duties for Company to a new
location that is at least fifty (50) miles from the prior location; provided that “Good Reason” shall not be deemed
to have occurred unless: (1) Executive provides Company with written notice that he intends to terminate his employment hereunder
for one of the grounds set forth above within thirty (30) days of such ground occurring, (2) if such ground is capable of being cured,
Company has failed to cure such ground within a period of thirty (30) days from the date of such written notice, and (3) Executive
terminates his employment within seventy-five (75) days from the date that Good Reason first occurs. For purposes of clarification, the
above-listed conditions shall apply separately to each occurrence of Good Reason and failure to adhere to such conditions in the event
of Good Reason shall not disqualify Executive from asserting Good Reason for any subsequent occurrence of Good Reason.

 

3.            Compensation.

 

(a)         Base
Salary. While Executive is employed hereunder, Company shall pay Executive a base salary at the annual rate of four hundred thirty
thousand ($430,000.00) (the “Base Salary”), payable in substantially equal periodic installments in accordance with Company’s
payroll practices as in effect from time to time. Company shall deduct from each such installment all amounts required to be deducted
or withheld under applicable law or under any employee benefit plan in which Executive participates.

 

(b)         Annual
Bonus. Executive shall be eligible for an annual incentive bonus with respect to each calendar year of employment with Company (the
 “Annual Bonus”). Executive’s target Annual Bonus amount shall be Fifty Percent (50%) of Executive’s Base Salary
(the “Target Amount”), provided that the Annual Bonus for Executive’s first year of employment shall be pro-rated to
reflect the Executive’s hire date. The Annual Bonus amount for any calendar year shall be subject to the Board (or the Compensation
Committee’s) assessment of Executive’s performance, business conditions at Company, and the terms of any applicable annual
bonus plan. The Annual Bonus, if any, shall be paid no later than March 15th of the calendar year following the calendar year to
which such Annual Bonus relates (the “Bonus Payment Date”). Executive must be employed
by Company on the Bonus Payment Date in order to be eligible for such Annual Bonus, except as set out in Section 4(a)(ii).

 

(c)          Equity.
The Company will grant Executive RSUs with an anticipated fair market value equal to $4,400,000. Such award will be granted on the first
regularly scheduled grant date on or after Executive’s Commencement Date, which is expected to be during the week of November 1,
2021 (“Next Grant Date”). The number of RSUs granted shall be calculated on the Next Grant Date based on the Company’s
closing stock price on the Next Grant Date. The RSUs will vest over a 3-year period commencing on the Commencement Date, with 1/3 of the
total number of RSUs vesting on each of the first, second, and third anniversaries of the Commencement Date, subject to Executive’s
continuous employment with the Company through each such vesting date, except as otherwise set out in Section 4(c)(iv) of this
Agreement. The RSUs will be subject to the terms and conditions of the Company’s 2021 Incentive Award Plan (“the “Plan”)
in effect as of the Next Grant Date and the Company’s standard form of applicable RSU Agreement for use with the Plan, which Executive
will be required to sign.

 

     

     

    

 

In addition, as part of the
Company’s projected annual grant cycle in Q1 2023 and annually thereafter, Executive will be eligible to receive an equity grant
with an anticipated fair market value of up to $2,200,000.00. Such annual award will be granted, subject to Board approval (or appropriate
Committee thereof) and conditional on Executive’s performance against pre-defined personal and corporate goals as a member of the
Company’s executive team, consistent with the timing of annual equity grants to all other Company employees, which is anticipated
to be in March 2023. The equity grant will be subject to the terms and conditions of the Company’s 2021 Incentive Award Plan
(the “Plan”) or an alternative equity plan in effect at the time of the grant and the Company’s applicable standard
form of equity agreement(s) issued in accordance with the Plan or alternative equity plan, which Executive will be required to sign.

 

(d)           Fringe
Benefits. Executive shall be entitled to participate in all benefit/welfare plans and fringe benefits provided to employees at the
same level as Executive. Executive understands that, except when prohibited by applicable law, Company’s benefit plans and fringe
benefits may be amended by Company from time to time in its sole discretion.

 

(e)           Paid
Time Off. Executive’s time off is not limited per year but must be scheduled to minimize disruption to Company’s operations,
pursuant to the terms and conditions of Company policy and practices as applied to Company senior executives. This policy is subject to
change in Company’s sole discretion. Paid time off is not accrued, earned, vested, or classified as a wage supplement and thus vacation
time will not be paid out to Executive upon separation of employment, regardless of the reason for the separation.

 

(f)            Reimbursement
of Expenses. Company shall reimburse Executive for all ordinary and reasonable out-of-pocket business expenses incurred by Executive
in furtherance of Company’s business in accordance with Company’s policies with respect thereto as in effect from time to
time. Executive must submit any request for reimbursement no later than ninety (90) days following the date that such business expense
is incurred. All reimbursements provided under this Agreement shall be made or provided in accordance with the requirements of Section 409A
of the Internal Revenue Code and the rules and regulations thereunder (“Section 409A”) including, where applicable,
the requirement that (i) any reimbursement is for expenses incurred during Executive’s lifetime (or during a shorter period
of time specified in this Agreement); (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect
the expenses eligible for reimbursement in any other calendar year; (iii) the reimbursement of an eligible expense shall be made
no later than the last day of the calendar year following the year in which the expense is incurred; and (iv) the right to reimbursement
or in kind benefits is not subject to liquidation or exchange for another benefit.

 

4.             Termination
and Severance Payments.

 

(a)          Payment of Accrued Obligations. Regardless of the reason for any employment
termination hereunder, Company shall pay to Executive: (i) the portion of Executive’s Base Salary that has accrued prior
to any termination of Executive’s employment with Company and has not yet been paid; (ii) any Annual Bonus under
Section 3(b) for the year preceding the year in which the termination occurred, to the extent unpaid; and (iii) the
amount of any expenses properly incurred by Executive on behalf of Company prior to any such termination and not yet reimbursed
(together, the “Accrued Obligations”) promptly following the effective date of termination. In the event that
Executive’s employment is terminated for any reason other than as described in Section 4(b) or 4(c) below,
Company shall pay the Accrued Obligations to Executive promptly following the effective date of such termination and shall have no
further obligations to Executive. Executive’s entitlement to any other compensation or benefit under any Company plan or
policy shall be governed by and determined in accordance with the terms of such plan or policy, except as otherwise specified in
this Agreement.

 

     

     

    

 

(b)           Standard
Severance. If Executive’s employment hereunder is terminated by Company without Cause or by Executive for Good Reason, then,
in addition to the Accrued Obligations, Company shall pay Executive the following:

 

(i)            An
amount equal to Executive’s monthly Base Salary for a twelve (12) month period (the “Severance Period”), with such payments
to be made during the Severance Period in accordance with Company’s normal payroll practices, less all customary and required taxes
and employment-related deductions.

 

(ii)           An
amount equal to One Hundred percent (100%) of Executive’s Target Amount of the Annual Bonus for the year in which the termination
occurs, paid in one lump sum amount within sixty (60) days following Executive’s termination date, less customary and required taxes
and employment-related deductions

 

(iii)           Subject
to Executive’s proper election to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(“COBRA”), Company shall pay to the group health plan provider or the COBRA provider a monthly payment equal to the monthly
employee and employer COBRA premiums to continue Executive’s coverage under Company’s group healthcare plan (including coverage
for Executive’s eligible dependents, if applicable) until the earliest of (A) the twelve (12) month anniversary of the date
of termination; (B) Executive’s eligibility for group health plan benefits under any other employer’s group medical plan;
or (C) the cessation of Executive’s continuation rights under COBRA; provided, if Company reasonably determines that
it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially violating applicable
law (including, without limitation, Section 2716 of the Public Health Service Act), then Company shall convert such payments to payroll
payments directly to Executive for the time period specified above. Such payments, if to Executive, shall be subject to tax-related deductions
and withholdings and paid on Company’s regular payroll dates.

 

(iv)          Notwithstanding
anything to the contrary in the Plan or any stock option agreement executed by Executive pursuant thereto, any stock option then vested
and exercisable as of Executive’s termination date may be exercised within twelve (12) months after Executive’s termination
date, but in no event later than the ten (10) year anniversary of the original date of grant or the original expiration date of the
stock option, whichever comes first (unless the Plan requires or authorizes earlier termination, including in connection with a liquidation
or sale of Company). Any unvested portion of any option shall not be exercisable and shall expire and be cancelled on Executive’s
termination date.

 

The payments and benefits
described in this Section 4(b) shall be referred to as the “Standard Severance,” and are expressly subject to the
conditions described in Section 4(d).

 

     

     

    

 

(c)            Change
of Control Severance. If a Change of Control (as defined below) occurs and, within a period of twelve (12) months following the Change
of Control, Executive’s employment hereunder is terminated by Company (or its successor) in connection with such Change of Control
without Cause or by Executive for Good Reason, then, in addition to the Accrued Obligations:

 

(i)            Executive
shall receive the severance payment described in and on the terms set forth in Section 4(b)(i).

 

(ii)           Executive
shall receive the severance bonus described in and on the terms set forth in Section 4(b)(ii).

 

(iii)          Executive
shall receive the benefits payments described in and on the terms set forth in Section 4(b)(iii).

 

(iv)        Notwithstanding
anything to the contrary in the Plan or any equity award agreement executed by Executive pursuant thereto, and subject to the terms and
conditions of the Plan and any equity agreements executed by Executive pursuant thereto, Executive automatically shall become vested in
one hundred percent (100%) of outstanding and unvested time-based equity awards granted to Executive by Company. Any termination or forfeiture
of any unvested portion of such time-based equity awards that would otherwise occur on the date of termination in the absence of this
Agreement shall be delayed until the effective date of the separation agreement described in Section 4(d) and shall only occur
if the vesting pursuant to this subsection does not occur due to the absence of such separation agreement becoming fully effective within
the time period set forth therein. Following such acceleration, Executive shall not have any right to acquire or vest in any other form
of equity under the Plan. In addition, any stock option may be exercised within twelve (12) months after Executive’s termination
date, but in no event later than the ten (10) year anniversary of the original date of grant or the original expiration date of the
stock option, whichever comes first (unless the Plan requires or authorizes earlier termination, including in connection with a liquidation
or sale of Company). Acceleration of vesting of stock options may cause certain stock options currently deemed to be incentive stock options
taxable in accordance with Section 422 of the Internal Revenue Code of 1986, as amended, to be converted into non-qualified stock
options which are taxable upon exercise. Executive acknowledges and agrees that Company does not guarantee or make any representations
regarding the tax consequences of this provision or the tax treatment of any stock options.

 

The payments and benefits
described in this Section 4(c) shall be referred to as the “Change of Control Severance,” and are expressly subject
to the conditions described in Section 4(d). In the event that Executive is eligible for the Change of Control Severance under Section 4(c),
except as expressly set forth herein, Executive shall not be eligible for the Standard Severance under Section 4(b).

 

For the purposes of this Section 4(c),
a “Change of Control” is defined as any of the following: (A)   Ownership:  Any “Person”
(as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the “Beneficial
Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of Company representing 50% or more
of the total voting power represented by Company’s then outstanding voting securities (excluding for this purpose any such voting
securities held by Company or its Affiliates or any employee benefit plan of Company) pursuant to a transaction or a series of related
transactions which the Board does not approve; or (B)  Merger/Sale of Assets: (1)  A merger or consolidation of Company
whether or not approved by the Board, other than a merger or consolidation which would result in the voting securities of Company outstanding
immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the
surviving entity or the parent of such corporation) more than 50% of the total voting power represented by the voting securities of Company
or such surviving entity or parent of such corporation, as the case may be, outstanding immediately after such merger or consolidation;
or (2) the sale, lease, transfer, exclusive license or other disposition by Company of all or substantially all of Company’s
assets in a transaction requiring stockholder approval. “Change of Control” shall be interpreted, if applicable, in a manner,
and limited to the extent necessary, so that it shall not cause adverse tax consequences under Section 409A of the Code.

 

     

     

    

 

(d)            Severance
Payment Conditions.

 

(i)            Release
Requirement. Company shall not be obligated to pay Executive the Standard Severance or Change of Control Severance (as applicable)
unless and until Executive has executed (without revocation) a timely separation agreement in a standard form that is acceptable to Company,
which shall include mutual releases and which must be signed by Executive and returned to Company no later than sixty (60) days following
Executive’s separation from service (the “Review Period”), and which shall include, at a minimum, a complete general
release of claims against Company and its affiliated entities and each of their officers, directors, employees and others associated
with Company and its affiliated entities, and in Company’s sole discretion, a one (1) year post-employment non-competition,
agreement. If Executive fails to return such agreement within the Review Period, then Executive’s Standard Severance or Change
of Control Severance (as applicable) shall be forfeited. If Executive executes and does not revoke such agreement within the Review Period,
then payment of the Standard Severance or Change of Control Severance (as applicable) shall commence on the first (1st) day
following the Review Period.

 

(ii)          Return
of Company Property. Company shall not be obligated to pay Executive the Standard Severance or Change of Control Severance (as applicable)
unless and until Executive has complied with his obligations to return Company information and property under Section 6.

 

(iii)          Non-Disparagement.
Executive shall not make any statements that are professionally or personally disparaging about, or adverse to, the interests of Company,
including, but not limited to, any statements that disparage any services or capabilities of Company.  Notwithstanding the foregoing,
nothing in this section shall restrict Executive from making any disclosures mandated by state or federal law, from participating in
an investigation with a state or federal agency if requested by the agency to do so, or from providing information or documents to a
state or federal agency if requested by the agency to do so.

 

(iv)          Impact
of Executive’s Breach. The Standard Severance or Change of Control Severance (as applicable) shall cease immediately in the
event that a court of competent jurisdiction enters a final order finding that Executive breached his Non-Competition, Non-Solicitation,
Non-Disclosure, and Intellectual Property Agreement (as described in Section 5).

 

(e)           Amounts
Owed. The payments and benefits set forth in this Section 4 shall be the sole amounts owing to Executive upon termination of
Executive’s employment for the reasons set forth above and Executive shall not be eligible for any other payments or other forms
of compensation or benefits. The payments and benefits set forth in Section 4 (as applicable) shall be the sole remedy, if any,
available to Executive in the event that he brings any claim against Company relating to the termination of his employment under this
Agreement.

 

     

     

    

 

5.          Prohibited
Competition and Solicitation. As a condition of Executive’s employment with Company,
Executive agrees to execute Company’s Non-Competition, Non-Solicitation, Non-Disclosure, and Intellectual Property Agreement, attached
hereto as Exhibit A.

 

6.          Property
and Records. Upon the termination of Executive’s employment hereunder for any reason
or for no reason, or if Company otherwise requests, Executive shall: (a) return to Company all Company confidential and proprietary
information, and copies thereof (regardless how such information or copies are maintained), and (b) deliver to Company any property
of Company which may be in Executive’s possession, including, but not limited to, tablet-type devices, laptops, cell phones, smart
phones, products, files, materials, memoranda, notes, records, reports or other documents or photocopies of the same, in either hard copy
or electronic form.

 

7.            Code
Sections 409A and 280G.

 

(a)           The
benefits set forth in Sections 4(b)-4(c) of this Agreement constitute “non-qualified deferred compensation” subject to
Section 409A. The following conditions apply to the payment of the benefits in Sections 4(b)-4(c): Any termination of Executive’s
employment triggering payment of benefits under Sections 4(b)-4(c) must constitute a “separation from service” under
Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) before distribution of such benefits can commence.
To the extent that the termination of Executive’s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of
the Code and Treas. Reg. §1.409A-1(h) (as the result of further services that are reasonably anticipated to be provided by Executive
to Company at the time Executive’s employment terminates), any benefits payable under Sections 4(b)-4(c) that constitute deferred
compensation under Section 409A shall be delayed until after the date of a subsequent event constituting a separation of service
under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h). For purposes of clarification, this Section shall
not cause any forfeiture of benefits on Executive’s part, but shall only act as a delay until such time as a “separation from
service” occurs. Further, if Executive is a “specified employee” (as that term is used in Section 409A and regulations
and other guidance issued thereunder) on the date his separation from service becomes effective, any benefits payable under Sections 4(b)-4(c) that
constitute non-qualified deferred compensation subject to Section 409A shall be delayed until the earlier of (i) the business
day following the six-month anniversary of the date his separation from service becomes effective, and (ii) the date of Executive’s
death, but only to the extent necessary to avoid the adverse tax consequences and penalties under Section 409A. On the earlier of
(i) the business day following the six-month anniversary of the date his separation from service becomes effective, and (ii) Executive’s
death, Company shall pay Executive in a lump sum the aggregate value of the non-qualified deferred compensation that Company otherwise
would have paid Executive prior to that date under Sections 4(b)-4(c). It is intended that each installment of the payments and benefits
provided under Sections 4(b)-4(c) shall be treated as a separate “payment” for purposes of Section 409A. Neither
Company nor Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically
permitted or required by Section 409A.

 

(b)           Notwithstanding
any other provision of this Agreement to the contrary, this Agreement shall be interpreted and at all times administered in a manner that
avoids the inclusion of compensation in income under Section 409A, or the payment of increased taxes, excise taxes or other penalties
under Section 409A.

 

(c)         The
Parties intend this Agreement to be in compliance with Section 409A. Executive acknowledges and agrees that Company does not guarantee
the tax treatment or tax consequences associated with any payment or benefit arising under this Agreement, including but not limited to
consequences related to Section 409A.

 

     

     

    

 

(d)          If
any payment or benefit Executive would receive under this Agreement, when combined with any other payment or benefit Executive receives
pursuant to a Change of Control (for purposes of this section, a “Payment”) would: (i) constitute a “parachute
payment” within the meaning of Section 280G the Code; and (ii) but for this sentence, be subject to the excise tax imposed
by Section 4999 of the Code (the “Excise Tax”), then such Payment shall be either: (A) the full amount of such Payment;
or (B) such lesser amount (with cash payments being reduced before stock option compensation) as would result in no portion of the
Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local
employments taxes, income taxes, and the Excise Tax, results in Executive’s receipt, on an after-tax basis, of the greater amount
of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.

 

8.            General.

 

(a)           Notices.
Except as otherwise specifically provided herein, any notice required or permitted by this Agreement shall be in writing and shall be
delivered as follows with notice deemed given as indicated: (i) by personal delivery when delivered personally; (ii) by overnight
courier upon written verification of receipt; (iii) by electronic mail upon verification of receipt; or (iv) by certified or
registered mail, return receipt requested, upon verification of receipt. Notices to Executive shall be sent to the last known address
in Company’s records or such other address as Executive may specify in writing. To whom notices to Company shall be sent shall be
decided by the Board at a later date.

 

(b)         Modifications
and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by the Parties
hereto.

 

(c)           Waivers
and Consents. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written
document executed by the Party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or
shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such
waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute
a continuing waiver or consent.

 

(d)         Assignment.
Company may assign its rights and obligations hereunder to any person or entity that succeeds to all or substantially all of Company’s
business or that aspect of Company’s business in which Executive is principally involved. Executive may not assign Executive’s
rights and obligations under this Agreement without the prior written consent of Company.

 

(e)           Governing
Law. This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by
the law of the Commonwealth of Massachusetts without giving effect to the conflict of law principles thereof. Any legal action or proceeding
with respect to this Agreement shall be brought in the courts of the Commonwealth of Massachusetts or the United States of America for
the District of Massachusetts. By execution and delivery of this Agreement, each of the parties hereto accepts for itself and in respect
of its property, generally and unconditionally, the exclusive jurisdiction of the aforesaid courts. ANY ACTION, DEMAND, CLAIM OR COUNTERCLAIM
ARISING UNDER OR RELATING TO THIS AGREEMENT SHALL BE RESOLVED BY A JUDGE ALONE AND EACH OF COMPANY AND EXECUTIVE WAIVES ANY RIGHT TO A
JURY TRIAL THEREOF.

 

     

     

    

 

(f)            Headings
and Captions. The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and shall
in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

(g)         Entire
Agreement. This Agreement, together with the applicable equity incentive award plan, form of stock option agreement, restricted stock
option agreement and/or equity award agreement, and any restrictive covenants agreement referenced herein, embodies the entire agreement
and understanding between the Parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements
and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement of any kind not
expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this
Agreement.

 

(h)           Counterparts.
This Agreement may be executed in two or more counterparts, and by different Parties hereto on separate counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the same instrument. For all purposes a signature by fax shall
be treated as an original.

 

(i)           Background
Check. The Parties acknowledge and agree that it is the Company’s policy to conduct a background check on all new hires
in accordance with applicable law. Accordingly, the execution and effectiveness of this Agreement is subject to the satisfactory completion
of a background check on the Executive. This process will be coordinated with the Company’s People team prior to execution.

 

(j)            Revocation
Right. The Parties acknowledge and agree that if this Agreement is executed by the Parties in advance of the Commencement Date, the
Company shall have the unconditional right to revoke this Agreement for Cause up to the Effective Date upon written notice by Company
to Executive under Sections 2(c)(i), 2(c)(ii), 2(d)(iv), 2(c)(v) or 2(c)(viii), which revocation shall be effective on the date of
such notice.

 

[Signature Page to Follow]

 

     

     

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the date first written above.

 

	EXECUTIVE	 	EVOLV TECHNOLOGIES
    HOLDINGS, INC.
	 	 	 
	 	 	 
	/s/ Mario Ramos	 	By: 	/s/
Peter George 
	Signature	 	 	Name: Peter George
	Address:   ####	 	 	Title:   CEO

 

     

     

    

 

EXHIBIT A

COVENANTS AGREEMENT

 

     

     

    

 

 

 

NON-DISCLOSURE, NON-COMPETITION, NON-SOLICITATION
AND INVENTIONS

ASSIGNMENT AGREEMENT

 

This Non-Disclosure, Non-Competition
Non-Solicitation and Inventions Assignment Agreement (the “Agreement”) is made by and between Evolv Technologies Holdings, Inc.
(hereinafter the “Company”), and the undersigned employee as of October 29, 2021.

 

For good and valuable consideration,
including, without limitation, your employment by the Company, access to the Company’s confidential information, trade secrets and
good will, and, with respect to the non-competition restrictions, the additional consideration set forth in Section 2(c)(i), you
and the Company agree as follows:

 

1.            Confidentiality.

 

(a)            Definition
of Confidential Information. For purposes of this Agreement, “Confidential Information” means trade secrets and
confidential and proprietary information of the Company, or any information provided to you or the Company under an obligation of confidentiality
to a third party, or any confidential, trade secret, or proprietary information acquired by the Company from others with whom the Company
or any affiliate has a business relationship, whether in written, oral, electronic or other form, including, but not limited to, technical
data and specifications, business and financial information, product and marketing plans, customer and client information, customer and
client lists, customer, client and vendor identities and characteristics, agreements, marketing knowledge and information, sales figures,
pricing information, marketing plans, business plans, strategy forecasts, financial information, budgets, software, projections and procedures,
the confidential evaluation of (and confidential use or non-use by the Company or any affiliate of) technical or business information
in the public domain, Inventions (as defined below), and any other scientific, technical or trade secrets of the Company or of any
third party provided to you or the Company under a condition of confidentiality, provided that Confidential Information shall not
include (i) information in your possession or known to you prior to employment with the Company, (ii) your contact lists, whether
in electronic or paper form (e.g. rolodex, Outlook contacts, etc.) that are in your possession or known to you prior to employment
with the Company, or (iii) any information that is generally known in the industry or is in the public domain other than through
any fault or act by you.1/

 

(b)            Protection
and Non-Disclosure of Confidential Information. You expressly acknowledge and agree that all Confidential Information is and shall
remain the sole property of the Company or the third party to whom the Company owes an obligation of confidentiality and that you shall
hold it in strictest confidence. You shall at all times, both during your employment with the Company and after your termination of employment
for any reason or for no reason, maintain in confidence and shall not, without the prior written consent of the Company, use (except in
the course of performance of your duties for the Company or by court order), disclose, or give to others any Confidential Information.
The terms of this Section 1 are in addition to, and not in lieu of, any statutory or other contractual or legal obligation that you
may have relating to the protection of the Company’s Confidential Information. The terms of this Section 1 shall survive indefinitely
any termination of your employment with the Company for any reason or for no reason.

 

(c)           Notice
Pursuant to Defend Trade Secrets Act. Notwithstanding any provision of this Agreement prohibiting the disclosure of Inventions (as
defined below) or other Confidential Information, you understand that you may not be held criminally or civilly liable under any federal
or state trade secret law for the disclosure of a Company trade secret that: (i) is made (A) in confidence to a federal, state
or local government official, either directly or indirectly, or to an attorney; and (B) solely for the purpose of reporting or investigating
a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing
is made under seal. In addition, if you file a lawsuit or other court proceeding against the Company for retaliating against you for reporting
a suspected violation of law, you may disclose the Company trade secret to the attorney representing you and use the Company trade secret
in the court proceeding, if you file any document containing the Company trade secret under seal and do not disclose the trade secret,
except pursuant to court order.

 

 

		1/	The term “trade secrets,” as used in this Agreement,
shall be given its broadest possible interpretation under applicable state and federal law.

 

 

    

     

    

 

(d)            Return
of Confidential Information. Upon the termination of your employment with the Company for any reason or for no reason, or if the Company
otherwise requests, you shall: (i) return to the Company all tangible Confidential Information and copies thereof (regardless how
such Confidential Information or copies are maintained); and (ii) deliver to the Company any property of the Company which may be
in your possession, including, but not limited to, products, materials, memoranda, notes, records, reports, or other documents or photocopies
of the same. Notwithstanding anything to the contrary in this Agreement, you may retain your contact lists, whether in electronic or paper
form (e.g. rolodex, Outlook contacts and calendar, etc.) that are in your possession or known to you prior to employment with the
Company, as well as copies of documents related to your compensation and benefits.

 

2.            Prohibited
Competition and Solicitation.

 

(a)           Acknowledgements
and Agreements Regarding Competition. You expressly acknowledge that: (i) there are competitive and proprietary aspects of the
business of the Company; (ii) during your employment with the Company, the Company shall furnish, disclose or make available to you
Confidential Information (as defined in Section 1) and may provide you with unique and specialized training; (iii) such Confidential
Information and training have been developed and shall be developed by the Company through the expenditure of substantial time, effort
and money, and could be used by you to compete with the Company; (iv) if you become employed or affiliated with any competitor of
the Company in violation of your obligations in this Agreement, it is inevitable that you would disclose the Confidential Information
to such competitor and would use such Confidential Information, knowingly or unknowingly, on behalf of such competitor; and (v) in
the course of your employment, you shall be introduced to vendors, suppliers, customers, employees, contractors and others with important
relationships to the Company, and any and all “goodwill” created through such introductions belongs exclusively to the Company,
including, but not limited to, any goodwill created as a result of direct or indirect contacts or relationships between you and any vendors,
suppliers or customers of the Company.

 

(b)           Definitions.

 

(i)            “Cause.”
The term “Cause” shall have the same definition as used in your Employment Agreement with the Company.

 

(ii)            “Competing.”
For the purposes of this Agreement, a business shall be deemed to be “Competing” with the Company if the business performs
or is planning to perform any of the same or similar services, manufacturing, research, or development provided by the Company during
the last two years of your employment by the Company; or is a business in which you could reasonably be expected to use or disclose Confidential
Information.

 

(iii)          “Non-Competition
Period.” The term “Non-Competition Period” is defined as the one (1) year period following the termination
of your employment with the Company for Cause, or your resignation for any reason or no reason, provided that, in the event that you breach
a fiduciary duty to the Company or unlawfully take physical or electronic property of the Company then the duration of the Non-Competition
Period shall be increased to two (2) years following the termination of your employment with the Company.

 

		2

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

(iv)           “Non-Solicitation
Period.” For the purposes of this Agreement, the term “Non-Solicitation Period” is defined as the one (1) year
period following the termination of your employment with the Company for any reason or for no reason.

 

(v)            “Restricted
Territory.” For the purposes of this Agreement, the term “Restricted Territory” is defined as any regional area
or territory in which you performed services on behalf of the Company or had a material presence or influence in the two years immediately
preceding the termination of your employment with the Company.

 

(c)            Non-Competition.
During the period in which you are employed by the Company and for the Non-Competition Period, you shall not engage in the following activities
either through or on behalf of yourself, a third party or another person/entity, whether directly or indirectly, either as principal,
partner, stockholder, officer, director, member, employee, consultant, agent, representative or in any other capacity: own, manage, operate
or control, or be concerned, connected or employed by, or otherwise associate in any manner with, engage in, or have a financial interest
in, any business which is directly or indirectly Competing with the business of the Company within the Restricted Territory (each, a “Restricted
Activity”). For the avoidance of doubt, this Section 2(c) shall not apply to you in the event your employment is
terminated without Cause or if the Company elects to waive this Section 2(c) in accordance with Section 2(c)(ii) below.

 

(i)            Garden
Leave. In consideration of your agreement not to compete during the Non-Competition Period as set forth above in Section 2(c),
and so long as you comply with the obligations under Section 2(c), the Company shall pay you an amount equal to fifty percent (50%)
of your highest annualized base salary in the two years immediately preceding the commencement of the Non-Competition Period, to be paid
in accordance with the Company’s normal payroll practices. For the purposes of this subsection 2(c)(i), “highest annualized
base salary” shall mean the highest averaged amount of compensation paid to you for any twelve month period during the two year
period immediately preceding commencement of the Non-Competition Period, but shall not include any other form of compensation, including
but not limited to, commissions, bonuses, reimbursement of expenses, travel discounts or other fringe benefits. The Company reserves the
right to apply any severance payments made to you by the Company, or a portion thereof, against the installment payments under this Section 2(c)(i).

 

(ii)           Waiver
of Non-Competition Period. The Company, in its sole discretion, may elect at any time prior to the commencement of the Non-Competition
Period, or on such later date to the extent permitted by applicable law, to waive the restrictions set forth in Section 2(c), which
such waiver shall automatically terminate Company’s obligations to compensate you under Section 2(c)(i) above. In such
event, you shall have no further obligation under Section 2(c) above. Such waiver shall be provided in writing by the Company.
Such waiver shall have no effect on your obligations under the remainder of this Agreement, which shall continue in full force and effect
in all respects. You acknowledge and agree that nothing in this Section 2(c)(ii) gives you an election as to compliance with
Section 2(c).

 

(iii)            Remedies
Upon Breach. You acknowledge and agree that if you breach any of your obligations under Section 2(c) of this Agreement at
any time during the Non-Competition Period, then, in addition to any other remedies that the Company may have against you, including but
not limited to injunctive relief, the Company shall immediately cease any and all payments to you pursuant to Section 2(c)(i) and
you shall be obligated to immediately return any and all payments previously made by the Company pursuant to Section 2(c)(i).

 

(iv)            Notice
of Subsequent Employment or Engagement. You agree that at any point prior to the commencement of the Non-Competition Period, in the
event that you are actively considering a post-employment professional opportunity (whether as an employee, consultant, contractor, director,
partner or otherwise), you shall notify Liza Knapp at the Company in writing of such opportunity. You acknowledge and agree that your
acceptance of the payments under Section 2(c)(i) shall be an express representation to the Company that you are in compliance
with this Section 2(c)(iv).

 

		3

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

(v)            Material
Breach. You acknowledge and agree that a breach of any provision of this Section 2(c) is a material breach of this Agreement.

 

(d)            Solicitation
of Customers. During the period in which you are employed by the Company and for the Non-Solicitation Period, you shall not engage
in the following activities either through or on behalf of yourself, a third party or another person/entity, whether directly or indirectly:
(i) solicit, divert or appropriate, or attempt to solicit, divert or appropriate, for the purpose of Competing with Company
within the Restricted Territory, the business or patronage of any customer, client, vendor, supplier, or patron of the Company, or the
business or patronage of any prospective customer, client, vendor, supplier, or patron to which the Company has developed or made a collaboration,
joint venture or sales presentation (or similar offering of services); or (ii) interfere with, or attempt to interfere with, the
relations between the Company and any customer, client, vendor, supplier or patron of the Company.

 

(e)            Solicitation
of Employees and Contractors. During the period in which you are employed by the Company and for the Non-Solicitation Period, you
shall not engage in the following activities either through or on behalf of yourself, a third party or another person/entity, whether
directly or indirectly: (i) solicit, entice or persuade, or attempt to solicit, entice or persuade, any other employees or contractors
of the Company to leave the services of the Company or any such parent, subsidiary or affiliate for any reason; or (ii) employ, cause
to be employed, or solicit the employment or services of any employee or contractor of the Company while any such person is providing
services to the Company or within six (6) months after any such person ceases providing services to the Company.

 

(f)            Tolling.
You acknowledge and agree that the Non-Solicitation Period shall be tolled and shall not run, during any period in which you are in violation
of the terms herein.

 

3.            Ownership
of Ideas, Copyrights and Patents.

 

(a)            Property
of the Company. All ideas, discoveries, creations, manuscripts and properties, innovations, improvements, know-how, inventions, designs,
developments, apparatus, techniques, methods, laboratory notebooks, formulae, data, protocols, writings, specifications, sound recordings,
and pictorial and graphical representations, (collectively the “Inventions”) which may be used in the business of
the Company, whether patentable, copyrightable or not, which you may conceive, reduce to practice or develop during your employment with
the Company, whether alone or in conjunction with another or others, whether during or out of regular business hours, whether or not
on the Company’s premises or with the use of its equipment, and whether at the request or upon the suggestion of the Company or
otherwise, shall be and are the sole and exclusive property of the Company, and that you shall not publish any of the Inventions without
the prior written consent of the Company or its designee. You acknowledge and agree that any Inventions conceived or made by you, alone
or with others, within six (6) months following termination of your employment are likely to have been conceived in significant
part while employed by the Company; accordingly, you agree that such Inventions shall be presumed to have been conceived during your
employment by the Company until you have established the contrary by clear and convincing evidence, and that such Inventions are subject
to the terms and conditions of this Section. You also acknowledge that all original works of authorship which are made by you (solely
or jointly with others) within the scope of your employment or which relate to the business of the Company or a Company affiliate and
which are protectable by copyright are “works made for hire” pursuant to the United States Copyright Act (17 U.S.C. §
101). You hereby assign to the Company or its designee all of your right, title and interest in and to all of the foregoing. You further
represent that, to the best of your knowledge and belief, none of the Inventions shall violate or infringe upon any right, patent, copyright,
trademark or right of privacy, or constitute libel or slander against or violate any other rights of any person, firm or corporation,
and that you shall use your best efforts to prevent any such violation.

 

		4

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

(b)            Invention
Disclosure; Cooperation; Power of Attorney. Promptly upon conception of any Invention, you agree to disclose the same to the Company
and the Company shall have full power and authority to file and prosecute patent applications thereon and to procure and maintain patents
thereon. You agree that such Inventions shall remain subject to all provisions of this Agreement, including but not limited to the ownership,
cooperation and licensing provisions described in this Section 3. You acknowledge that your obligation to disclose such information
is ongoing during your employment with the Company, and that after you execute this Agreement, if you determine that any additional Inventions
in which you claim or intend to claim any right, title or interest (including but not limited to patent, copyright and trademark interest)
has been or is likely to be delivered to the Company or incorporated in any company product or system, you shall make immediate written
disclosure of the same to the Company. At any time during or after your employment with the Company, you shall fully cooperate with the
Company and its attorneys and agents in securing and protecting the Company’s rights to Inventions, including but not limited to
the preparation and filing of all papers and other documents as may be required to perfect the Company’s rights in and to any of
such Inventions, and joining in any proceeding to obtain letters patent, copyrights, trademarks or other legal rights with respect to
any such Inventions in the United States and in any and all other countries, provided that the Company shall bear the expense of such
proceedings, and that any patent or other legal right so issued to you personally shall be assigned by you to the Company or its designee
without charge by you. If the Company is unable, after reasonable effort, to secure your signature on any such papers and/or other documents,
you hereby irrevocably designate and appoint each officer of the Company as your agent and attorney-in-fact to execute any such papers
on your behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and interests
in any Invention.

 

(c)            Licensing
and Use of Innovations. With respect to any Inventions, and work of any similar nature (from any source), whenever created, which
you have not conceived, reduced to practice or developed during the period that you are employed by the Company, but which you provide
to the Company or incorporate in any Company product or system, you hereby grant to the Company a royalty-free, fully paid-up, non-exclusive,
perpetual and irrevocable license throughout the world to use, modify, create derivative works from, disclose, publish, translate, reproduce,
deliver, perform, sell, license, dispose of, and to authorize others so to do, all such Inventions. You shall not include in any Inventions
you deliver to the Company or use on its behalf, without the prior written consent of the Company, any material which is or shall be patented,
copyrighted or trademarked by you or others unless you provide the Company with the written permission of the holder of any patent, copyright
or trademark owner for the Company to use such material in a manner consistent with then-current Company policy.

 

(d)            Prior
Inventions. You have attached hereto, as Exhibit A, a list describing all Inventions, whether patentable or not, which
were created, made, conceived or reduced to practice by you prior to your employment by the Company and which are owned by you, which
relate directly or indirectly to the current or anticipated future business of the Company, and which are not assigned to the Company
hereunder (collectively, “Prior Inventions”); or, if no such list is attached, you represent that there are no such
Prior Inventions. If disclosure of any Prior Invention would cause you to violate any prior confidentiality agreement, you understand
that you will not to list these Prior Inventions in Exhibit A but will only to disclose a cursory name for each invention, a listing
of the party(ies) to whom it belongs and the fact that full disclosure as to the inventions has not been made for that reason.

 

4.            Disclosure
to Future Employers. You shall provide, and the Company, in its discretion, may similarly provide, a copy of this Agreement
or specific covenants herein to any business or enterprise which you may directly or indirectly own, manage, operate, finance, join, control
or in which you may participate in the ownership, management, operation, financing, or control, or with which you may be connected as
an officer, director, employee, partner, principal, agent, representative, consultant or otherwise.

 

		5

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

5.            Your
Representations and Warranties. You hereby represent and warrant that: (a) you have no commitments, agreements or
legal obligations that are inconsistent with this Agreement or that restrict your ability to be employed by or perform other services
for the Company; and (b) the Company has advised you that at no time should you divulge to or use for the benefit of the Company
any trade secret or confidential or proprietary information of any previous employer or other third party, and that you have not divulged
or used and shall not divulge or use any such information for the benefit of the Company. You expressly acknowledge and agree that you
shall indemnify and hold the Company harmless against loss, damage, liability or expense arising from any claim based upon circumstances
alleged to be inconsistent with the representations and warranties above.

 

6.            Provisions
Necessary and Reasonable; Injunctive Relief.

 

(a)            Reasonableness
of Restrictions. You acknowledge and agree that the provisions of Sections 1, 2 and 3 of this Agreement are necessary and reasonable
to protect the Company’s Confidential Information, property rights, trade secrets, goodwill and business interests. You further
acknowledge and agree that the types of employment which are prohibited by Section 2 are narrow and reasonable in relation to the
skills which represent your principal salable asset both to the Company and to your other prospective employers, and that the specific
but broad temporal and geographical scope of Section 2 is reasonable and fair in light of the Company’s need to market its
services and develop and sell its products in a large geographic area in order to maintain a sufficient customer base, and in light of
your material presence or influence in the Restricted Territory during the last two years of your employment with the Company.

 

(b)            Injunctive
Relief. You hereby expressly acknowledge that any breach or threatened breach of any of the terms of Sections 1, 2 or 3 of this Agreement
shall result in substantial, continuing and irreparable injury to the Company. Therefore, in addition to any other remedy available to
the Company, the Company shall be entitled to injunctive or other equitable relief by a court of appropriate jurisdiction in the event
of any breach or threatened breach of the terms of Sections 1, 2 or 3 of this Agreement, without posting any bond or security, and without
affecting the Company’s right to seek and obtain damages or other equitable relief.

 

7.            General.

 

(a)            Entire
Agreement. This Agreement embodies the entire agreement and understanding between the parties hereto with respect to the subject matter
hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation,
warranty, covenant or agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or
restrict, the express terms and provisions of this Agreement. You expressly agree that any change or changes in your job duties, authority,
title, reporting relationship, territory, salary or compensation after the signing of this Agreement shall not affect the validity or
scope of this Agreement.

 

(b)            Modifications
and Amendments. The terms and provisions of this Agreement may be modified or amended only by written agreement executed by the parties
hereto.

 

(c)            Assignment.
The Company may assign its rights and obligations hereunder to any person or entity that succeeds to all or substantially all of the Company’s
business or that aspect of the Company’s business in which you are principally involved. You may not assign your rights and obligations
under this Agreement without the prior written consent of the Company and any such attempted assignment by you without the prior written
consent of the Company shall be void.

 

		6

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

(d)           Governing
Law; Jurisdiction; Venue; Waiver of Jury Trial. This Agreement and the rights and obligations of the parties hereunder shall be construed
in accordance with and governed by the law of the Commonwealth of Massachusetts, without giving effect to conflict of law principles thereof,
and specifically excluding any conflict or choice of law rule or principle that might otherwise refer construction or interpretation
of this Agreement to the substantive law of another jurisdiction. Any legal action or proceeding with respect to this Agreement shall
be brought in Suffolk County Superior Court Business Litigation Session, Boston, Massachusetts. By execution and delivery of this Agreement,
each of the parties hereto accepts for itself and in respect of its property, generally and unconditionally, the exclusive jurisdiction
of the aforesaid court. ANY ACTION, DEMAND, CLAIM OR COUNTERCLAIM ARISING UNDER OR RELATING TO THIS AGREEMENT SHALL BE RESOLVED BY
A JUDGE ALONE AND EACH OF THE COMPANY AND YOU WAIVE ANY RIGHT TO A JURY TRIAL THEREOF.

 

(e)            Severability
and Blue Pencil. The parties intend this Agreement to be enforced as written. However, (i) if any portion or provision of this
Agreement is to any extent declared illegal or unenforceable by a duly authorized court having jurisdiction, then the remainder of this
Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or
unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest
extent permitted by law; and (ii) if any provision, or part thereof, is held to be unenforceable because of the duration of such
provision or the geographic area covered thereby, the court making such determination shall have the power to reduce the duration and/or
geographic area of such provision, and/or to delete specific words and phrases (“blue-penciling”), and in its reduced
or blue-penciled form such provision shall then be enforceable and shall be enforced.

 

(f)            Survival
of Acknowledgements and Agreements. Your acknowledgements and agreements set forth in Sections 1, 2 and 3 shall survive the termination
of your employment by the Company for any reason or for no reason, pursuant to the terms and conditions herein.

 

(g)           Headings
and Captions. The headings and captions of the various subdivisions of this Agreement are for convenience of reference only and shall
in no way modify or affect the meaning or construction of any of the terms or provisions hereof.

 

(h)            No
Waiver of Rights, Powers and Remedies. The terms and provisions of this Agreement may be waived, or consent for the departure therefrom
granted, only by a written document executed by the party entitled to the benefits of such terms or provisions. The election of any remedy
by a party hereto shall not constitute a waiver of the right of such party to pursue other available remedies.

 

(i)            Expenses.
In any action between the parties arising out of or connected with this Agreement (including arbitration), the prevailing party as determined
by the fact finder (the “Prevailing Party”) in such action shall be awarded, in addition to any damages, injunctions or other
relief, its costs and expenses, not limited to taxable costs, and reasonable attorneys’, accountants’ and experts’ fees,
and costs, unless otherwise stipulated in this Agreement.

 

(j)            Counterparts.
This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the same instrument.

 

(k)           Acknowledgment;
Opportunity to Review. You hereby acknowledge that you have been provided an opportunity to review the terms and conditions set forth
in this Agreement including the obligations and agreements under Section 2(c), upon the earlier of a formal offer of employment or
ten (10) business days before the commencement of employment, and that you have had the opportunity to consult with counsel of your
own choosing regarding such terms. You further acknowledge that you fully understand the terms of this Agreement and have voluntarily
executed this Agreement, including that your obligations hereunder may limit your right to accept certain future job opportunities that
require you to engage in Restricted Activities.

 

If the foregoing accurately
sets forth our agreement, please so indicate by signing and returning to us the enclosed copy of this Agreement.

 

		7

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

	 	EVOLV TECHNOLOGIES HOLDINGS, INC.
	 	 
	 	/s/ Peter George
	 	Peter George
	 	Chief Executive Officer

 

	Accepted
    and Agreed:	 
	 	 
	/s/
    Mario Ramos	 
	Signature	 
	 	 
	Mario
    Ramos	 
	Printed
    Name	 
	 	 
	October 29,
    2021	 
	Date	 

 

		8

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

     

    

 

EXHIBIT A

PRIOR INVENTIONS

 

		9

 

    ©Copyright 2021 Evolv Technologies, Inc. All Rights Reserved.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]